A detailed history of Ubs Group Ag transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 233,372 shares of MRVI stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
233,372
Previous 167,023 39.72%
Holding current value
$1.31 Million
Previous $1.2 Million 62.26%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.84 - $9.73 $453,827 - $645,575
66,349 Added 39.72%
233,372 $1.94 Million
Q2 2024

Aug 13, 2024

BUY
$6.87 - $11.34 $528,680 - $872,669
76,955 Added 85.44%
167,023 $1.2 Million
Q1 2024

May 13, 2024

SELL
$5.11 - $8.76 $324,101 - $555,603
-63,425 Reduced 41.32%
90,068 $780,000
Q4 2023

Feb 09, 2024

BUY
$4.7 - $9.87 $452,219 - $949,661
96,217 Added 167.99%
153,493 $1.01 Million
Q3 2023

Nov 09, 2023

SELL
$9.14 - $12.85 $769,514 - $1.08 Million
-84,192 Reduced 59.51%
57,276 $572,000
Q2 2023

Aug 11, 2023

BUY
$12.09 - $15.0 $333,974 - $414,360
27,624 Added 24.26%
141,468 $1.76 Million
Q1 2023

May 12, 2023

BUY
$12.99 - $16.48 $300,718 - $381,512
23,150 Added 25.53%
113,844 $1.59 Million
Q4 2022

Feb 08, 2023

BUY
$12.5 - $24.78 $84,200 - $166,918
6,736 Added 8.02%
90,694 $1.3 Million
Q3 2022

Nov 10, 2022

SELL
$20.6 - $30.37 $188,922 - $278,523
-9,171 Reduced 9.85%
83,958 $2.14 Million
Q2 2022

Aug 10, 2022

SELL
$26.05 - $37.48 $213,636 - $307,373
-8,201 Reduced 8.09%
93,129 $2.65 Million
Q1 2022

May 16, 2022

SELL
$24.46 - $40.92 $496,586 - $830,757
-20,302 Reduced 16.69%
101,330 $3.57 Million
Q4 2021

Feb 14, 2022

SELL
$35.0 - $45.94 $614,390 - $806,430
-17,554 Reduced 12.61%
121,632 $5.1 Million
Q3 2021

Nov 15, 2021

SELL
$36.8 - $60.62 $422,500 - $695,978
-11,481 Reduced 7.62%
139,186 $6.83 Million
Q2 2021

Aug 13, 2021

BUY
$32.46 - $45.0 $2.61 Million - $3.62 Million
80,369 Added 114.33%
150,667 $6.29 Million
Q1 2021

May 12, 2021

BUY
$25.8 - $38.49 $888,113 - $1.32 Million
34,423 Added 95.95%
70,298 $2.51 Million
Q4 2020

Feb 11, 2021

BUY
$24.5 - $30.86 $878,937 - $1.11 Million
35,875 New
35,875 $1.01 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $738M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.